URMC / New York Influenza Center of Excellence / Publications / 2014 Publications 2014 Publications 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | Archived 2014, Dec Peng X, Alföldi J, Gori K, Eisfeld AJ, Tyler SR, Tisoncik-Go J, Brawand D, Law GL, Skunca N, Hatta M, Gasper DJ, Kelly SM, Chang J, Thomas MJ, Johnson J, Berlin AM, Lara M, Russell P, Swofford R, Turner-Maier J, Young S, Hourlier T, Aken B, Searle S, Sun X, Yi Y, Suresh M, Tumpey TM, Siepel A, Wisely SM, Dessimoz C, Kawaoka Y, Birren BW, Lindblad-Toh K, Di Palma F, Engelhardt JF, Palermo RE, Katze MG The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease. PMID: 25402615 Richards KA, Nayak J, Chaves FA, DiPiazza A, Knowlden ZA, Alam S, Treanor JJ, Sant AJ Season influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenza. PMID: 25492919 Ramon S, Baker SF, Sahler JM, Kim N, Feldsott EA, Serhan CN, et al. The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant? PMID : 25392529 DeVito SR, Ortiz-Riano E, Martinez-Sobrido L, Munger J Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylation. PMID : 25472841 2014, Nov Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, Reyes-Terán G, Ross TM, Wilson PC, Ahmed R, Bloom JD, Hensley SE Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. PMID: 25331901 2014, Oct Guo H, Baker SF, Martinez-Sobrido L, Topham DJ Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus. PMID : 25100831 Costello DA, Whittaker GR, Daniel S Variations in pH sensitivity, acid stability, and fusogenicity of three influenza virus H3 subtypes. PMID: 25320308 Linel P, Wu S, Deng N, Wu H Dynamic transcriptional signatures and network responses for clinical symptoms in influenza-infected human subjects using systems biology approaches. PMID : 25015847 2014, Sept Baker SF, Nogales A, Finch C, Tuffy KM, Domm W, Perez DR, et al. Influenza A and B virus intertypic reassortment through compatible viral packaging signals. PMID : 25008914 Nogales A, Baker SF, Ortiz-Riano E, Dewhurst S, Topham DJ, Martinez-Sobrido L Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development. PMID : 24965472 Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, Pantin-Jackwood MJ, Tumpey TM, Katze MG H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza and associated with lethal outcome in mice. PMID : 24991006 2014, Aug de Wit E, Rasmussen AL, Feldmann F, Bushmaker T, Martellaro C, Haddock E, Okumura A, Proll SC, Chang J, Gardner D, Katze MG, Munster VJ, Feldmann H Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tract of cynomolgus macaques. PMID : 25118237 2014, Jul Hamilton BS, Chung C, Cyphers SY, Rinaldi VD, Marcano VC, Whittaker GR. Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2. PMID : 24978308 2014, May Nayak JL, Richards KA, Yang H, Treanor JJ, Sant AJ Effect of Influenza (H5N1) Vaccine Prepandemic Priming on CD4+ T-cell response. PMID : 25378637 2014, Feb 4 Josset L, Zeng H, Kelly SM, Tumpey TM, Katze MG. Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options. PMID : 24496798